Form 4: Tyra Biosciences CEO Acquires Additional Shares Through Employee Stock Purchase Plan
SEC Form 4 Filing
Todd Harris, President and CEO of Tyra Biosciences, acquired 1,350 shares of common stock through the company's Employee Stock Purchase Plan on September 13, 2024.
Summary
- On September 13, 2024, Todd Harris, the President and CEO of Tyra Biosciences, acquired 1,350 shares of the company's common stock.
- The shares were purchased through the Issuer's 2021 Employee Stock Purchase Plan at a price of $6.579 per share.
- Following the transaction, Harris directly owns 1,505,927 shares of Tyra Biosciences common stock.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. The CEO's purchase indicates confidence, but it's a routine transaction through an employee stock purchase plan.
Positives
- The CEO's participation in the Employee Stock Purchase Plan demonstrates confidence in the company's future.
Industry Context
Insider transactions are routinely monitored and reported to the SEC. Purchases by executives can be interpreted as a positive signal, but should be considered in the context of the overall financial health and strategic direction of the company.
Stakeholder Impact
- The transaction could have a slightly positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 09/13/2024 | Date of the stock acquisition by Todd Harris. |
| 09/17/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.